×
I agree that ALK Canada may contact me via email and phone about relevant content, products, services, company news, and events. ALK Canada may only use my personal information in accordance with its Privacy Policy. I understand that I can withdraw my consent at any time. J'accepte qu'ALK Canada me contacte par courriel et par téléphone au sujet du contenu, des produits, des services, des nouvelles de l'entreprise et des événements pertinents. ALK Canada ne peut utiliser mes renseignements personnels qu'en conformité avec sa politique de confidentialité. Je comprends que je peux retirer mon consentement en tout temps.
Skip this step and download
What You Need to Know
Thu, Nov. 27, 2025
7:30–8:15 PM (EST)
5:30–6:15 PM (MST)
4:30–5:15 PM (PST)
Free, Live Virtual Event
Dr. Mary Elizabeth
Noseworthy, MD

Pediatric Respirologist
Why is it important to target the underlying cause of allergic rhinitis?

There’s more beneath the surface of allergic rhinits than you might think. What looks like nasal congestion, runny nose, and itchy, watery eyes could be just the tip of the iceberg. Underneath lies a complex immune response that starts well before symptoms appear.

Join our LIVE webinar on November 27 as pediatric respirologist, Dr. Mary Elizabeth Noseworthy explores:
  • Why early diagnosis matters
  • The full range of treatment options available for children
  • How addressing the underlying cause, including allergy immunotherapy, may benefit eligible pediatric patients with allergic rhinitis

Date: Thursday, November 27, 2025
Time: 7:30–8:15 PM (EST) 5:30–6:15 PM (MST) 4:30–5:15 PM (PST)

Meet your speaker
Dr. Mary Elizabeth
Noseworthy, MD
Pediatric Respirologist
Dr. Noseworthy graduated from Memorial University with a BSc in Biochemistry (Honours) and completed her pediatric subspecialty training at Memorial University and the Janeway Child Health Center in St. John’s Newfoundland. Dr. Noseworthy furthered her expertise with fellowship training in Pediatric Respiratory Medicine at the Hospital for Sick Children in Toronto. Since moving to Alberta in 2009, Dr. Noseworthy has focused on severe asthma research and quality assurance in medicine. Currently a Clinical Assistant Professor at the Cumming School of Medicine in Calgary, she received an Innovative Research Award from the Department of Pediatrics for her work with the KIDsPRO asthma project alongside Dr. Maria Santana, developing the electronic Pediatric Provincial Asthma Pathway now used across all pediatric ER departments in Alberta.
What to expect

Gain a deeper understanding of the burden of AR in children, recognizing the need to treat.

Understand where pharmaceutical therapies and allergy immunotherapy (AIT) fit into the overall treatment algorithm for children.

Confidently expand treatment approaches and feel more assured recommending allergy immunotherapy in children where appropriate.

Access to post-webinar material including resources to help you implement strategies you’ve learned into your practice immediately.

Live Q & A with Dr. Noseworthy at the end of the session.

Opportunity to provide feedback on what you liked, what/who you would like to see more of in the future, hot topics, etc.

Who should attend?

Any healthcare professional managing children with allergic rhinitis

Pediatricians

Family Physicians

Nurse Practitioners

ENT Specialists

Respirologists

Allergists

Pharmacists

Can’t make it to the webinar?

Register anyway, and we’ll send you a summary of key takeaways and supplemental resources to review on your own time.

Ref 1: Keith et al p3A: “72% of patients indicated that during allergy season their AR symptoms adveresly impacted their daily lives”